Skip to main content
Year archive

aap Implantate AG — 2021 filings

All 50 regulatory filings released by aap Implantate AG (AAQ1) in 2021, sourced directly from the official regulator.

50 Filings
2021 Period
2021 filings (50)
Filing Released Lang
aap: Supervisory Board extends Management Board contracts until end of 2023
Board/Management Information
2021-12-17 English
aap launches world's first human clinical study for antibacterial silver coating technology on anatomical plates and screws for fracture treatment
Environmental & Social Information
2021-12-10 English
Adjustment of conversion price of convertible bond 2020/2023 (ISIN DE000A3E46M4) to EUR 1.61 after implemented capital increase
Capital/Financing Update
2021-11-25 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-17 English
Ongoing impact of aap's restructuring clearly reflected in Q3 and 9M sales, earnings, and cash flow
Earnings Release 9M 2021
2021-11-12 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-10 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-10 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-05 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-05 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-10-28 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-10-27 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2021-10-27 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2021-10-27 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-10-26 English
Successful capital increase with significant oversubscription: Appreciation of management's performance in aap's transformation process in COVID-19 times; financing secured at least until end of 2023
Share Issue/Capital Change
2021-10-21 English
Result of the capital increase with subscription rights: capital measure significantly oversubscribed; issue of 1.5 million new shares leads to gross issue proceeds of almost EUR 5 million
Capital/Financing Update
2021-10-20 English
aap's transformation continues: Marc Langner strengthens Supervisory Board
Board/Management Information
2021-10-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2021-10-05 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2021-10-05 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2021-10-05 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2021-10-05 English
DGAP-DD: aap Implantate AG english
Director's Dealing
2021-10-05 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-10-04 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-10-04 English
Turnaround after successful restructuring paves way for capital increase starting today - Attractive offer for shareholders and new investors
Share Issue/Capital Change
2021-10-04 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-09-30 English
aap Implantate AG resolves on capital increase with subscription rights to finance sales growth and start of human clinical study for antibacterial silver coating technology
Share Issue/Capital Change
2021-09-27 English
Disruptive antibacterial silver coating technology: Very good results after use of 3 silver-coated implants as positive indication for start of human clinical study in Q4/21
Regulatory Filings
2021-09-21 English
aap Implantate AG significantly raises EBITDA forecast for financial year 2021
Earnings Release FY 2021
2021-09-16 English
aap with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1)
Earnings Release H1 2021
2021-08-13 English
Halbjahresfinanzbericht 2021
Interim / Quarterly Report H1 2021
2021-08-13 German
Report Publication Announcement 2021
Report Publication Announcement
2021-08-09 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2021 bis zum 30.06.2021
Report Publication Announcement
2021-08-09 German
aap: Significant sales increases in Q2 (+74%) and H1 (+37%) underline growth targets for FY/2021; USA for first time with EUR 1 million sales quarter
Earnings Release H1 2021
2021-07-27 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-06-30 English
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
Report Publication Announcement
2021-06-25 German
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 15.07.2021 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2021-06-22 German
Antibacterial silver coating technology: aap's silver coated implant used for first time in patient
Regulatory Filings
2021-06-18 English
Q1/21: Successful start to the year with sales growth (+9%) and significant earnings improvement (+91%) despite still burdening COVID-19 pandemic - restructuring successes clearly visible
Earnings Release Q1 2021
2021-05-28 English
aap Implantate AG: Significant year-on-year earnings improvement (+91%) in Q1/2021 with almost balanced EBITDA (EUR -0.2 million)
Earnings Release Q1 2021
2021-05-19 English
2020 financial statements: visible results under restructuring with significantly improved Recurring EBITDA (+28%) in challenging times of COVID-19 pandemic
Earnings Release FY 2020
2021-04-30 English
Jahresfinanzbericht 2020
Annual Report FY 2020
2021-04-30 German
Refusal of audit opinions for annual financial report 2020 (HGB) and consolidated annual financial report 2020 (IFRS); measures to secure further financing in implementation
Audit Report / Information FY 2020
2021-04-29 English
Report Publication Announcement 2021
Report Publication Announcement
2021-04-28 English
Hinweis auf Jahresfinanzbericht vom 01.01.2020 bis zum 31.12.2020
Report Publication Announcement
2021-04-28 German
Q1/2021: Solid start to year with 9% sales growth despite still burdening COVID 19 pandemic; more than 500 surgeries in US mark new high; Q2 order book well filled
Earnings Release Q1 2021
2021-04-26 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 English
Publication of annual financial statements 2020 on 30 April 2021
Report Publication Announcement
2021-03-10 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2021-01-29 English
FY/2020: Sales of EUR 9.3 million in Corona year in upper half of guidance - dynamic sales growth in USA (+41%); significant sales growth and positive EBITDA in trauma business planned for FY/2021
Earnings Release FY 2020
2021-01-21 English